Brain‐derived neurotrophic factor overexpression in taste buds diminishes chemotherapy induced taste loss

Vismodegib is used in patients suffering from advanced basal cell carcinoma (BCC), but 100% of the patients taking it report dysgeusia and 50% discontinue the treatment. Treatment with neurotrophic factors can stimulate neuronal survival and functional improvement in injured organs. Here, we analyse...

Descripción completa

Detalles Bibliográficos
Autores principales: Vukmanovic Nosrat, Irina, Palacios, Jerry L., Kezian, Steven, Luong, Gloria, Tran, Andrew, Vu, Kim, Henson, Bradley S., Nosrat, Philip, Lutfy, Kabirullah, Nosrat, Christopher A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Molecular and Synaptic Mechanisms
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804163/
https://www.ncbi.nlm.nih.gov/pubmed/35986485
http://dx.doi.org/10.1111/ejn.15799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804163/
https://www.ncbi.nlm.nih.gov/pubmed/35986485
http://dx.doi.org/10.1111/ejn.15799

Ejemplares similares